Video Update with Dr. Daniel Koller

Investors seem to have little interest in biotech stocks at the moment. Is the skepticism investors are showing justified and how does this compare with the fundamental development of the sector or the individual companies? These and other questions are explored in the video update with Dr. Daniel Koller, Head of the Investment Management Team.